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Abstract Background During neurally adjusted ventilatory assist (NAVA)/noninvasive (NIV)
NAVA, a modified nasogastric feeding tube with electrodes monitors the electrical
activity of the diaphragm (Edi). The Edi waveform determines the delivered pressure
from the ventilator.
Objective Our objective was to determine whether NAVA/NIV-NAVA has advantages
in infants with evolving/established bronchopulmonary dysplasia (BPD).
Methods Each infant who received NAVA/NIV-NAVA and conventional invasive and
NIV was matched with two historical controls. Eighteen NAVA/NIV-NAVA infants’
median gestational age, 25.3 (23.6–28.1) weeks, was compared with 36 historical
controls’ median gestational age 25.2 (23.1–29.1) weeks.
Results Infants on NAVA/NIV-NAVA had lower extubation failure rates (median: 0 [0–
2] vs. 1 [0–6] p¼0.002), shorter durations of invasive ventilation (median: 30.5, [1–90]
vs. 40.5 [11–199] days, p¼0.046), and total duration of invasive and NIV to the point of
discharge to the local hospital (median: 80 [57–140] vs. 103.5 [60–246] days,
p¼0.026). The overall length of stay (LOS) was lower in NAVA/NIVNAVA group
(111.5 [78–183] vs. 140 [82–266] days, p¼0.019). There were no significant differ-
ences in BPD (17/18 [94%] vs. 32/36 [89%] p¼0.511) or home oxygen rates (14/18
[78%] vs. 23/36 [64%] p¼ 0.305).
Conclusion The combination of NAVA/NIV-NAVA compared with conventional inva-
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Despite improvements in survival rates of extremely pre-
term-born infants, the incidence of bronchopulmonary dys-
plasia (BPD) remains unchanged over the last two decades.1
As invasive ventilation is frequently necessary and indeed
life-saving, numerous ventilator strategies have been devel-
oped to reduce damage to the developing lung. Synchroniza-
tion of mechanical breaths with the patient’s respiratory
effort offers the theoretical benefit of improving oxygenation
requirement with lower ventilator pressures, fewer air leaks,
and increased patient comfort with less sedation require-
ments.2 During neurally adjusted ventilatory assist (NAVA)/
noninvasive (NIV)-NAVA, a modified nasogastric feeding
tube with electrodes monitors the electrical activity of the
diaphragm (Edi).3 The Edi waveform determines the magni-
tude of the delivered pressure from the ventilator. NAVA
allows the infant to initiate support of inspiration and
termination of inspiration, potentially allowing efficient
ventilation at lower pressures. Infants breath in synchrony
with the ventilator and therefore are more comfortable with
less work of breathing.3 Furthermore, using the respiratory
drive of the infant to control ventilation may help avoid
hypocarbia and hypercarbia.4 NIV neurally adjusted ventila-
tor assist (NIV-NAVA) allows coordination of the infant’s
respiratory efforts with initiation, termination, and degree
of inspiratory pressure above positive end-expiratory pres-
sure (PEEP) provided by the Maquet Servo N device.5 NIV-
NAVA has been successfully used clinically in neonates as a
mode of ventilation to prevent intubation to allow early
extubation and as a novel way to deliver nasal continuous
positive airway pressure.6 It is not, however, known if this
technique is better than other NIV techniques.
NIV-NAVA has not been assessed in infants with
evolving/established BPD. The aim of our study was to assess
whether NAVA followed by NIV-NAVA and other convention-
almodes of invasive and NIV ventilation had advantages over
conventional flow triggered volume-targeted assist control
ventilation (VTV), assist control ventilation (ACV), and syn-
chronized intermittent mandatory ventilation (SIMV) inva-
sive modes of ventilation and conventional NIV modes such
as triggered bilevel positive airway pressure (BiPAP tr),
bilevel positive airway pressure (BiPAP), continuous positive
airway pressure (CPAP), and heated humidified high-flow
nasal cannula oxygen (HHFNC).
Materials and Methods
A retrospective study was undertaken in infants with evolv-
ing or developed BPD. Premature infants born less than
32 weeks of gestational age requiring invasive ventilation
support beyond the second week (14 days) of postnatal age
were classified as infants who have evolving BPD, and
premature infants born less than 32 weeks of gestational
age requiring respiratory support at corrected 36 weeks of
gestational agewere deemed as infantswho have established
BPD. Each infant who received NAVA/NIV-NAVA and other
conventional modes of invasive (VTV, ACV, or SIMV) and NIV
ventilation (nasal intermittent positive pressure ventilation
such asNIPPV, BiPAP, CPAP, orHHFNC)wasmatchedwith two
other infants (controls) supported by conventional invasive
and NIV ventilation. Matching was by gestational age, birth
weight, sex, antenatal steroid exposure, and if inborn/or
transferred ex utero. Infants were identified from a stan-
dardized electronic neonatal database (Badgernet). Data
were obtained from the electronic documentation recording
system and cross checkedwith themedical notes. NAVA/NIV-
NAVA was delivered by the SERVO-n Maquet Getinge venti-
lator and conventional ventilation (flow sensor triggered) by
the Stephanie STEPHAN ventilator and NIV modes were
BiPAP tr/BiPAP/CPAP (infant flow driver) and HHFNC (Vapo-
therm). Outcomes were extubation failure, duration of inva-
sive and NIV ventilation, total length of hospital stay (LOS),
BPD, and home supplementary oxygen rates. The study
period was between June 2019 and November 2020. The
infants were compared with a historical cohort born be-
tween June 2016 and January 2019. This project was regis-
tered with St George’s University Hospitals NHS Foundation
Trust (SGH) Audit department.
Infants were historically and routinely supported by
the Stephanie ventilator (Stephan GMBH, Gackenbach,
Germany). VTV, ACV, SIMV, and nontriggered NIV modes
including BiPAP tr, BiPAP, CPAP (flow driver), and HHFNC
were the standard ventilation modes for infants born pre-
maturely. The standard initial mode of invasive ventilation
was AC-VTV for most infants and if the clinical decision was
made to change over to pressure mode then ACV or SIMV
was considered based on the blood gases and gestational
age of the infant. The standard initial mode of NIV ventila-
tion was BiPAP tr/BiPAP or CPAP and changed to HHFNC
based on circuit change dates and departmental policy.7
Infants were considered for extubation by the attending
clinician if they had an improved work of breathing and/or
acceptable blood gases and/or improvement in their FiO2
requirement as per unit protocol. From June 2019, Stepha-
nie ventilator (Stephan GMBH, Gackenbach, Germany) ven-
tilators were transitioned to Maquet Servo N ventilators
which are currently the only ventilators which have NAVA
ventilation modality. When on NAVA, the apnea time was
set to 2 seconds and the upper pressure limit at least 5 cm
H2O higher than the baseline settings. A 6-French 49- or
50-cm Edi catheter was inserted via the orogastric route
and correct positioning confirmed as per the instructions of
the manufacturer using the Edi catheter positioning guide
function on the ventilator (Maquet Servo-n User Manual
Version 4.1). The guide function displays the retrocardiac
electrocardiogram (ECG) and correct positioning was con-
firmed when the P waves and QRS complexes were visible
in the uppermost leads and then decreased in size until the
P waves disappeared in the lowest lead. Colored highlight-
ing of the central two leads appeared once the catheter was
in the correct place. Once correct positioning was con-
firmed, the catheter was securely attached to the infant’s
face using an adhesive dressing. Before the infant was
changed to NAVA mode from conventional ventilation
(VTV, ACV, or SIMV), the NAVA level was adjusted so that
the estimated pressure waveform on NAVA closely matched
the actual pressure waveform on the baseline settings,
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aiming for the peak Edi to be between 5 to 15 µV as per the
recommendations of the manufacturer. The baseline venti-
lator settings were used to determine the back-up settings
to be used on NAVA in the absence of an Edi signal. Once
weaned to NAVA level of 0.8 to 1.0 cm H2O/mV then infants
were extubated onto NIV-NAVA mode on SERVO-n Maquet
Getinge ventilator. The apnea time was set to 2 seconds and
the upper pressure limit at least 5 cm H2O higher than the
baseline settings.
Extubation failure was defined as infants requiring intuba-
tion and ventilation within 72hours of being extubated. The
durationofoverall ventilationandNIVventilation includeddays
spent at the local hospital after being discharged from the
tertiary center. BPDwas defined as need of oxygen at corrected
36 weeks of gestation as per National Institute of Child Health
and Human Development (NICHD) definition8 and home oxy-
gen included infants discharged on home oxygen from the
tertiary center or the local hospital.
Sample Size Calculation
A sample size of 18 infants in the NAVAN/NIV-NAVA group
and 36 controls allowed detection of a 20% reduction in the
overall duration of invasive and NIV ventilation days in the
NAVA/NIV-NAVA group controlled to the controls with 80%
power and a significance level of 0.05.
Statistical Analysis
Differences between the two groups were assessed for
statistical significance using the Chi-square test or the
Mann–Whitney test as appropriate using IBM SPPS statistical
software, V.26 (IBM Corporation).
Results
Eighteen consecutive “NAVA” infants, median gestational age
25.3 (range: 23.6–28.1) weeks, were compared with 36
controls, median gestational age 25.2 (range: 23.1–29.1)
weeks (►Table 1). Infants were commenced on NAVA/NIV-
NAVA at a median postnatal age of 20 (range: 2–95) days.
Infants on NAVA/NIV NAVA had lower extubation failure
rates (median: 0 [0–2] vs. 1 [0–6] p¼0.002). Infants on
NAVA/NIV NAVA group had a shorter duration of invasive
ventilation (median: 30.5 [1–90] vs. 40.5 [11–199] days
p¼0.046) and total duration of invasive and NIV ventilation
up to the point of discharge to home from the local hospital
(median: 80 [57–140] vs. 103.5 [60–246] days p¼0.026).
There were no significant differences in BPD rates (17/18
[94%] vs. 32/36 [89%] p¼0.511) and home oxygen rates
14/18 [78%] vs. 23/36 [64%] p¼0.305) between infants on
NAVA/NIV NAVA group and infants in the control group
(►Table 2).
Discussion
Wehave demonstrated that in infants born very prematurely
and with evolving or established BPD a combination of
NAVA/NIV-NAVA compared with conventional invasive and
NIV modes have lower extubation failure rates, shorter
duration of invasive ventilation, total duration of ventilation
(invasive and NIV) and length of hospital stay.
Premature extubation carries hazards including lung
decruitment, compromised gas exchange, inspiratory mus-
cle fatigue, and ultimately the need for reintubation.9 Indeed,
Table 1 Demographic data
NAVA/NIV NAVA (n¼ 18) Control (n¼ 36) p-Value
BW (g) 685 (580–1060) 700 (540–1060) 0.7
GA (wk) 25.3 (23.6–28.1) 25.2 (23.1–29.1) 0.9
Gender (male/total) 10/18 (56) 22/36 (61) 1
Antenatal steroids (yes/total) 17/18 (94) 34/36 (94) 1
In utero/ex utero (in utero/total) 13/18 (72) 27/36 (75) 0.8
Abbreviations: BW, birth weight; GA, gestational age; NAVA, neurally adjusted ventilatory assist; NIV, noninvasive.
Note: Data displayed as median (range) or n (%).
Table 2 Results by ventilatory mode
NAVA/NIV NAVA (n¼18) Control (n¼ 36) p-Value
Extubation failure rates (n) 0 (0–2) 1 (0–6) 0.002
Duration of invasive ventilation (d) 30.5 (2–95) 40.5 (11–199) 0.046
Overall duration of invasive and NIV (d) 80 (57–140) 103.5 (60–246) 0.026
Overall LOS (d) 111.5 (78–183) 140 (82–266) 0.019
BPD 17/18 (94) 32/36 (89) 0.511
Home oxygen 14/18 (78) 23/36 (64) 0.305
Abbreviations: BPD, bronchopulmonary dysplasia; LOS, length of stay; NAVA, neurally adjusted ventilatory assist; NIV, noninvasive.
Note: Data displayed as median (range) or n (%).
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rates of extubation failure in extremely preterm infants have
been reported to be between 10 and 70%, depending on the
population studied and the time frame or criteria used to
define failure.10,11 In a pilot study,12 30 mechanically venti-
lated preterm infants were randomized at the time of initial
elective extubation to NIV-NAVA or NIPPV (nasal intermit-
tent positive pressure ventilation). Rates of continuous suc-
cessful extubation for 120hwere 92% in the NIV-NAVA group
and 69% in the NIPPV group (p¼0.14). Infants extubated to
NIV-NAVA remained extubated longer (median: 18 vs. 4 days,
p¼0.02) and experienced lower peak inspiratory pressures
(PIP) than infants managed with NIPPV throughout the first
3 days after extubation. Our study showed similar results
with significant lower extubation failure rates in the
NAVA/NIV-NAVA group.
Our study showed significant reductions in the overall
duration of invasive ventilation, total duration of ventilation
(invasive and NIV), and length of hospital stay. A recent pub-
lished study comparing 15 premature infants on NAVA/NIV-
NAVA born with birth weight of less than 1,500g showed no
statistically significantdifference in total durationof respiratory
support, severity of BPD, home oxygen therapies and length of
hospital stay when compared with a historical cohort group.13
That study,13 in comparison toour study,hada relativelymature
groupof infants,mediangestational ageof28.1weeks, andbirth
weight 965g versus 25.3weeks and birthweight of 685g in our
study. Thecomparisoncohort selectedwasby1 to1matching to
the NAVA patient compared with 2 to 1 in our study.
Therewerenostatistically significantdifferences in theBPD
or supplementary home oxygen rates between the NAVA-
NIVNAVA and the control group. NAVA at the tertiary center
was used in themajority of the patientswithmore severe lung
disease;NAVAwascommencedat amedianpostnatal age of 20
(range:2–95)daysand in infantswhoweredifficultwean from
conventional ventilation. Despite this, transition to NAVA
ventilation was well tolerated in all patients. An increasing
severe BPD trend toward the NAVA group was noted in one
study (8/15 vs. 3/15); however, this was not statistically
significant and similarly to our study they found no significant
difference in the home oxygen therapy rates.13
Limitations
There are strengths and some limitations to our study.
Within the study, the only significant change was the intro-
duction of NAVA/ NIV-NAVA mode which is a modality
specific to the Maquet ventilator. This is a retrospective
study comparing to a historical cohort receiving convention-
al invasive and NIV modes of ventilation. There may be a
variety of confounders that could influence the outcome of
the study. Hence, the controls were matched for gestational
age, birth weight, sex, antenatal steroid exposure, and if
inborn/or transferred ex utero.
Conclusion
In conclusion, we have demonstrated that in infants born
very prematurely andwith evolving or established BPD that a
combination of NAVA/NIV-NAVA comparedwith convention-
al invasive and NIV modes may be advantageous for preterm
infants with evolving or established BPD.
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